The Challenge
To support its growing research in viral agents, Fujifilm Diosynth Biotechnologies required a team of biosafety experts to evaluate its existing facilities and develop a strategy for a new BSL-3 laboratory. The company engaged World BioHazTec to perform a feasibility study of the current spaces and select a suitable site. This required detailed analysis to provide both short-term and long-term solutions for the laboratory’s design and infrastructure needs.
The Solution
World BioHazTec’s team conducted an in-depth site survey of the existing facilities and designed a tailored strategy for Fujifilm Diosynth. The proposed approach included both immediate and future steps to ensure the company’s research goals could be met safely and efficiently.
In the short term, the team recommended preparing an existing site for use as a temporary BSL-3 laboratory. This involved collaborating with an engineering design firm to address essential changes in drainage and airflow. The goal was to enable Fujifilm Diosynth to begin work in a functional BSL-3 space as soon as possible.
For the long-term solution, the team recommended constructing a dedicated, modular BSL-3 laboratory that would meet ANSI Standard Z9.14, BMBL 5th Edition guidelines, and CDC and NIH certification criteria. The modular design would maximize flexibility, allowing for future deconstruction and relocation. This BSL-3 lab would be built as a standalone unit with a separate exhaust module.
The Result
Upon completion of the feasibility study, World BioHazTec presented Fujifilm Diosynth with a comprehensive Feasibility Study Report. The report included a Decision Matrix that outlined the recommended strategy and site selection for the new laboratory. It also provided qualitative budget estimates to give Fujifilm Diosynth an understanding of the potential costs involved in the project.
Thanks to World BioHazTec’s strategic approach and expert recommendations, Fujifilm Diosynth Biotechnologies received a clear, actionable plan to expand its biocontainment capabilities while ensuring safety, efficiency, and compliance with industry standards. The feasibility study laid the groundwork for a state-of-the-art BSL-3 lab that will support their cutting-edge research for years to come.
Related Success Stories
ThirdLaw Molecular, Blue Bell, Pennsylvania
Allegheny County Health Department, Pittsburgh, Pennsylvania
Western University of Health Sciences, Pomona, California
World BioHazTec is an Accredited Provider (AP) of the International Association for Continuing Education and Training (IACET). As an IACET Accredited Provider, World BioHazTec offers IACET CEUs for its learning events that comply with the ANSI/IACET Continuing Education and Training Information.